Search

Margret B Basinski

from Noblesville, IN

Margret Basinski Phones & Addresses

  • 20509 State Road 37 N, Noblesville, IN 46060

Us Patents

  • Dna Encoding Rhesus Ob Protein

    view source
  • US Patent:
    6395509, May 28, 2002
  • Filed:
    May 26, 1995
  • Appl. No.:
    08/452228
  • Inventors:
    Margret B. Basinski - Indianapolis IN
    Brigitte E. Schoner - Monrovia IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    C12P 2106
  • US Classification:
    435 691, 4353201, 4352523, 435325, 435 711, 536 235, 536 2351
  • Abstract:
    The invention includes isolated nucleic acid molecules encoding a Rhesus ob gene product that regulates obesity in mammals. A preferred embodiment consisting of a native DNA sequence is disclosed, as are vectors and methods for expressing the Rhesus ob gene product.
  • Anti-Obesity Proteins

    view source
  • US Patent:
    58519955, Dec 22, 1998
  • Filed:
    Aug 4, 1997
  • Appl. No.:
    8/905694
  • Inventors:
    Margret B. Basinski - Indianapolis IN
    Richard D. DiMarchi - Carmel IN
    David B. Flora - Greenfield IN
    William F. Heath - Fishers IN
    James A. Hoffmann - Greenwood IN
    Brigitte E. Schoner - Monrovia IN
    James E. Shields - Noblesville IN
    David L. Smiley - Greenfield IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    A61K 3800
  • US Classification:
    514 12
  • Abstract:
    The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
  • Anti-Obesity Proteins

    view source
  • US Patent:
    55525237, Sep 3, 1996
  • Filed:
    Feb 6, 1995
  • Appl. No.:
    8/384183
  • Inventors:
    Margret B. Basinski - Indianapolis IN
    Richard D. DiMarchi - Carmel IN
    William F. Heath - Fishers IN
    Brigitte E. Schoner - Monrovia IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    A61K 3800
    C07K 710
    C07K 700
  • US Classification:
    530324
  • Abstract:
    The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
  • Anti-Obesity Proteins

    view source
  • US Patent:
    55525245, Sep 3, 1996
  • Filed:
    Feb 6, 1995
  • Appl. No.:
    8/384292
  • Inventors:
    Margret B. Basinski - Indianapolis IN
    Richard D. DiMarchi - Carmel IN
    William F. Heath - Fishers IN
    Brigitte E. Schoner - Monrovia IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    A61K 3800
    C07K 700
    C07K 710
  • US Classification:
    530324
  • Abstract:
    The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
  • Anti-Obesity Proteins

    view source
  • US Patent:
    56913095, Nov 25, 1997
  • Filed:
    Feb 6, 1995
  • Appl. No.:
    8/383650
  • Inventors:
    Margret B. Basinski - Indianapolis IN
    Richard D. DiMarchi - Carmel IN
    David B. Flora - Greenfield IN
    William F. Heath - Fishers IN
    James A. Hoffmann - Greenwood IN
    Brigitte E. Schoner - Monrovia IN
    James E. Shields - Noblesville IN
    David L. Smiley - Greenfield IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    A61K 3800
    C07K 100
    C07K 700
    C07K 500
  • US Classification:
    514 12
  • Abstract:
    The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
  • Anti-Obesity Proteins

    view source
  • US Patent:
    55678033, Oct 22, 1996
  • Filed:
    Feb 6, 1995
  • Appl. No.:
    8/383649
  • Inventors:
    Margret Basinski - Indianapolis IN
    Richard D. DiMarchi - Carmel IN
    David B. Flora - Greenfield IN
    William F. Heath - Fishers IN
    James A. Hoffmann - Greenwood IN
    Brigitte E. Schoner - Monrovia IN
    James E. Shields - Noblesville IN
    David L. Smiley - Greenfield IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    A61K 3800
    C07K 710
  • US Classification:
    530324
  • Abstract:
    The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
  • Anti-Obesity Proteins

    view source
  • US Patent:
    55697445, Oct 29, 1996
  • Filed:
    Feb 6, 1995
  • Appl. No.:
    8/383632
  • Inventors:
    Margret B. Basinski - Indianapolis IN
    Richard D. DiMarchi - Carmel IN
    David B. Flora - Greenfield IN
    William F. Heath - Fishers IN
    James A. Hoffmann - Greenwood IN
    Brigitte E. Schoner - Monrovia IN
    James E. Shields - Noblesville IN
    David L. Smiley - Greenfield IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    A61K 3800
    C07K 1400
  • US Classification:
    530324
  • Abstract:
    The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.
  • Anti-Obesity Proteins

    view source
  • US Patent:
    55941044, Jan 14, 1997
  • Filed:
    Feb 6, 1995
  • Appl. No.:
    8/384492
  • Inventors:
    Margret B. Basinski - Indianapolis IN
    Richard D. DiMarchi - Carmel IN
    David B. Flora - Greenfield IN
    William F. Heath - Fishers IN
    James A. Hoffmann - Greenwood IN
    Brigitte E. Schoner - Monrovia IN
    James E. Shields - Noblesville IN
    David L. Smiley - Greenfield IN
  • Assignee:
    Eli Lilly and Company - Indianapolis IN
  • International Classification:
    A61K 3800
    C07K 710
    C07K 700
  • US Classification:
    530324
  • Abstract:
    The present invention provides anti-obesity proteins, which when administered to a patient regulate fat tissue. Accordingly, such agents allow patients to overcome their obesity handicap and live normal lives with much reduced risk for type II diabetes, cardiovascular disease and cancer.

Get Report for Margret B Basinski from Noblesville, IN
Control profile